Pablo D T Valenzuela

Title: Pablo D T Valenzuela: Innovator in Virus Antigen Synthesis

Introduction

Pablo D T Valenzuela is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the synthesis of human virus antigens using yeast. With a total of 2 patents, Valenzuela's work has advanced our understanding of viral proteins and their applications in medicine.

Latest Patents

Valenzuela's latest patents focus on the synthesis of human virus antigens by yeast. The first patent details the synthesis of HB Ag in yeast, where yeast expression vectors comprising a yeast promoter, ADH1, have been constructed. The HBV genome coding for the S-protein has been transferred to the yeast expression vector, leading to the successful synthesis of HB Ag. This product is antigenic and shows a substantial portion associated with particles that resemble those found in the serum of HBV-infected patients. The second patent similarly addresses the synthesis of HBsAg in yeast, demonstrating the successful assembly of a higher ordered multi-component structure resulting from the expression of a heterologous DNA coding segment in a microorganism.

Career Highlights

Valenzuela is affiliated with the University of California, where he continues to conduct research and develop innovative solutions in the field of biotechnology. His work has not only contributed to scientific knowledge but has also paved the way for potential therapeutic applications.

Collaborations

Throughout his career, Valenzuela has collaborated with notable scientists such as William J Rutter and Benjamin D Hall. These collaborations have further enriched his research and expanded the impact of his inventions.

Conclusion

Pablo D T Valenzuela is a key figure in the field of biotechnology, with a focus on the synthesis of human virus antigens. His innovative work and collaborations have significantly advanced the understanding of viral proteins and their potential applications in medicine.